Technology
Health
Biotechnology
Harvard Bioscience
$2.369876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.42%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell HBIO and other stocks, options, ETFs, and crypto commission-free!
About
Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. Read More It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Employees
547
Headquarters
Holliston, Massachusetts
Founded
1901
Market Cap
88.94M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
168.24K
High Today
$2.43
Low Today
$2.34
Open Price
$2.34
Volume
97.63K
52 Week High
$6.70
52 Week Low
$2.26
Collections
Technology
Health
Biotechnology
US
North America
News
Seeking AlphaMay 3
Harvard Bioscience, Inc. (HBIO) CEO Jeffrey Duchemin on Q1 2019 Results - Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants Corey Manchester – Vice President and Corporate Controller Jeffrey Duchemin – President and Chief Executive Officer Kam Unninayar – Chief Financial Officer Conference Call Participants Paul Knight – Janney Montgomery Bruce Jackson – Benchmark Lisa Springer – Singular Research Operator Welcome to the Q1 2019 Harvard Bioscience Incorporated Earnings Conference Call. My name is Adrienne...
Price Paid on Robinhood
30% Lower
Right Now
52 Week Low
$2.26
Average Price Paid
$3.36
52 Week High
$6.70
Earnings
$0.02
$0.04
$0.05
$0.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 25, After Hours